CERo Therapeutics (CERO) announces its Board of Directors has appointed Chris Ehrlich as CEO. Previously he held the position of Interim CEO.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERO:
- Cero Therapeutics files to sell 210M shares of common stock for holders
- 3 Penny Stocks to Watch Now, 11/19/24
- Cero Therapeutics receives FDA clearance of IND application for CER-1236
- 3 Penny Stocks to Watch Now, 11/14/24
- CERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer Data